{"id":"W2113122060","doi":"10.1056/nejmoa1103799","title":"A Phase 3 Trial of Bevacizumab in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2152,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"Medicine; Bevacizumab; Hazard ratio; Ovarian cancer; Internal medicine; Carboplatin; Regimen; Oncology; Progression-free survival; Interim analysis; Cancer; Confidence interval; Surgery; Randomized controlled trial; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002290286,0.0008614853,0.001392377,0.0004464934,0.0004029663,0.0007742223,0.0005960674,0.001235524,0.006702343],"category_scores_gemma":[0.002402966,0.0003342617,0.001153286,0.0004321903,0.0006270422,0.0005847184,0.0004389932,0.002618324,0.0008636515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001011837,"about_ca_system_score_gemma":0.001596251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001071466,"about_ca_topic_score_gemma":0.002533271,"domain_scores_codex":[0.999095,0.000630726,0.00003049235,0.0000887492,0.00006396018,0.00009107191],"domain_scores_gemma":[0.9987197,0.0003536416,0.0003041494,0.0001010419,0.00008597702,0.0004355248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9090154,0.01169393,0.002693851,0.000867819,0.001081476,0.0001318648,0.0001149496,0.001271219,0.004856473,0.0003614163,0.006719907,0.06119176],"study_design_scores_gemma":[0.9333218,0.0587999,0.003583718,0.00004901767,0.000234569,0.00009922052,0.00001651513,0.0005573371,0.0003668258,0.0003767698,0.00258492,0.000009392035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9659727,0.008894815,0.001391788,0.003504483,0.0007140532,0.01006768,0.003355863,0.0001879444,0.005910641],"genre_scores_gemma":[0.9688239,0.003067039,0.003175524,0.004363962,0.0004054231,0.01344171,0.003338597,0.00004815967,0.0033358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006702343,"threshold_uncertainty_score":0.02242154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06633579281492227,"score_gpt":0.3510873405610243,"score_spread":0.284751547746102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}